Study Overview
- Principal Investigator: Bradford Dickerson, MD
- Sponsors: Philanthropic Funds and the National Institutes of Health (NIH)
- Conditions Studied: Posterior Cortical Atrophy (PCA), early-onset Alzheimer’s disease (eoAD), and cognitively normal (CN) control participants.
Purpose of the Study
In this research study we want to learn more about how the process of healthy aging in cognitive normal individuals differs from specific diseases of the brain, such as posterior cortical atrophy (PCA) and early-onset Alzheimer’s disease (eoAD).
Study Details
It will take approximately five years to complete this study, though participants can choose to leave the study at any time. The study consists of one baseline visit and two follow-up visits per year. The baseline visit will last approximately 4-5 hours in total, over a few 1-2 hour sessions, and will require neurocognitive testing administered either remotely or in person.
What to Expect
The following procedures will happen each year:
- A brief physical and neurological exam
- Neurocognitive testing
- Questionnaires about mood and functioning
Contact Information
If you are interested in learning more about this research study, please contact Katie Cunningham (kcunningham15@mgh.harvard.edu)